All In Biotech

Drug Trial Radar · NCT00938717

Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide Administered Orally for 26 Weeks in Patients With Irritable Bowel Syndrome With Constipation

Last checked: Nov 19, 2026Latest source record: Nov 5, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 805 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

805

Actual

Start

Jul 2009

Primary completion

Sep 2010

Study completion Sep 2010

Sponsor

Lead sponsor
Ironwood Pharmaceuticals, Inc.Industry
Sponsor type
Industry
Collaborators
Forest Laboratories
First posted
Jul 14, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine the safety and efficacy of linaclotide administered to patients with Irritable Bowel Syndrome with Constipation (IBS-C).

Conditions

  • Irritable Bowel Syndrome With Constipation

Interventions

  • Linaclotide or Matching PlaceboDrug

    Linaclotide or Matching Placebo, administered orally, once daily, for the duration of the trial

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Abdominal Pain and Complete Spontaneous Bowel Movement (APC) Responder, 9 Out of 12 WeeksTime frame: Change from Baseline to Week 12
  2. Complete Spontaneous Bowel Movement (CSBM) 3+1 Responder, 9 Out of 12 WeeksTime frame: Change from Baseline to Week 12
  3. Abdominal Pain Responder, 9 Out of 12 WeeksTime frame: Change from Baseline to Week 12
  4. Abdominal Pain and Complete Spontaneous Bowel Movement (APC) Responder, 6 Out of 12 WeeksTime frame: Change from Baseline to Week 12

Locations

107 sites in 1 country. Site status is shown where the registry gives one.

  • Ironwood Investigational Site

    Birmingham, Alabama

  • Ironwood Investigational Site

    Huntsville, Alabama

  • Ironwood Investigational Site

    Phoenix, Arizona

  • Ironwood Investigational Site

    Tempe, Arizona

  • Ironwood Investigational Site

    Tucson, Arizona

  • Ironwood Investigational Site

    Tucson, Arizona

  • Ironwood Investigational Site

    Sherwood, Arkansas

  • Ironwood Investigational Site

    Anaheim, California

  • Ironwood Investigational Site

    Chula Vista, California

  • Ironwood Investigational Site

    Encinitas, California

  • Ironwood Investigational Site

    Garden Grove, California

  • Ironwood Investigational Site

    Laguna Hills, California

  • Ironwood Investigational Site

    Orange, California

  • Ironwood Investigational Site

    San Carlos, California

  • Ironwood Investigational Site

    San Diego, California

  • Ironwood Investigational Site

    San Diego, California

  • Ironwood Investigational Site

    San Diego, California

  • Ironwood Investigational Site

    Colorado Springs, Colorado

  • Ironwood Investigational Site

    Bristol, Connecticut

  • Ironwood Investigational Site

    Boynton Beach, Florida

  • Ironwood Investigational Site

    Hollywood, Florida

  • Ironwood Investigational Site

    Inverness, Florida

  • Ironwood Investigational Site

    Jacksonville, Florida

  • Ironwood Investigational Site

    Jacksonville, Florida

  • Ironwood Investigational Site

    Lauderdale Lakes, Florida

  • Ironwood Investigational Site

    Miami, Florida

  • Ironwood Investigational Site

    Pinellas Park, Florida

  • Ironwood Investigational Site

    Tampa, Florida

  • Ironwood Investigational Site

    Newnan, Georgia

  • Ironwood Investigational Site

    Peoria, Illinois

  • Ironwood Investigational Site

    Anderson, Indiana

  • Ironwood Investigational Site

    Clive, Iowa

  • Ironwood Investigational Site

    Davenport, Iowa

  • Ironwood Investigational Site

    Mission, Kansas

  • Ironwood Investigational Site

    Overland Park, Kansas

  • Ironwood Investigational Site

    Topeka, Kansas

  • Ironwood Investigational Site

    Baton Rouge, Louisiana

  • Ironwood Investigational Site

    Metairie, Louisiana

  • Ironwood Investigational Site

    Monroe, Louisiana

  • Ironwood Investigational Site

    Shreveport, Louisiana

Showing 40 of 107 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.